SCARLETRED Holding GmbH

Today’s skincare market is aiming to develop and provide efficient treatment solutions for more than 3,000 skin diseases. Driven by this challenge, combined with the high medical need, a multitude of new or improved formulas are under constant development and get released each year into a fast growing and highly diverse global Dermatology market.Despite of the fact that there are tremendous international R&D activities in Biopharma, Cosmetics, and Medical industry there is an extreme lack of objective technologies for easy detecting, monitoring and analysis of the investigated skin issues and for validating safety and efficacy of the tested treatment options. The visual assessment of skin disorders is limited in precision and can be highly time-consuming, often leading to weak information and results, especially when the study size or observed effects are small. In the end, inefficient procedures costs healthcare providers a lot of time and money and can lower also the change of a treatment success. Thus novel and state of the art digital solutions for global health care industry and patients are required.